Concepedia

Publication | Open Access

Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)

63

Citations

17

References

2024

Year

Abstract

ClinicalTrials.gov Identifier: NCT04606602.

References

YearCitations

Page 1